查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604696

人工泪液市场：按产品类型、应用、交付模式划分 - 2025-2030 年全球预测

Artificial Tears Market by Product Type (Cellulose-derived, Glycerin-derived, Oil-based Emulsion), Application (Contact Lens Moisture, Dry Eye Treatment), Delivery Mode - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年人工泪液市场价值为20.6亿美元，预计到2024年将达到22.3亿美元，复合年增长率为8.27%，预计到2030年将达到36亿美元。

人工泪液市场主要集中在眼睛润滑和水合作用的产品，主要用于缓解眼睛干燥和发炎。人工泪液的需求源自于多种情况，例如干眼症、长时间使用萤幕、老龄化和环境因素。人工泪液的应用范围已不仅限于简单的眼睛补水，还包括手术后护理和改善隐形眼镜使用者的视觉舒适度。最终用户范围从个人消费者到医疗机构，涵盖零售、医疗领域等广泛领域。关键的成长要素包括增加使用可能导致眼睛疲劳的数位设备、更容易患干眼症的人口老化以及产品配方的创新，例如无防腐剂选项和先进的输送系统。最近的机会来自于人们对眼睛健康意识的增强和对非处方药（OTC）产品的需求增加，这凸显了品牌需要增加在零售店和电子商务管道的影响力。

主要市场统计
基准年[2023] 20.6亿美元
预计年份 [2024] 22.3亿美元
预测年份 [2030] 36亿美元
复合年增长率（%） 8.27%

然而，市场成长面临挑战，例如影响消费者信心的产品召回事件以及医疗产品严格的监管障碍。与现有製药公司的竞争和品牌忠诚度也是主要障碍。多功能人工泪液的开发、环保包装和人工智慧驱动的个人化眼部护理解决方案等领域的创新机会已经成熟。因此，企业应该投资新配方的研发，并利用数位行销来吸引精通科技的消费者。此外，我们可以透过与医疗保健提供者合作来加强我们的分销网络。了解监管环境和消费行为的区域差异对于优化市场渗透策略至关重要。儘管该市场目前由消费者主导，重点关注北美和亚太地区的成长，但策略性地理扩张和技术投资的结合可以扩大 Masu 的未来成长前景。为了充分利用市场机会，同时应对独特的挑战，公司必须适应永续性趋势，并优先考虑消费者的眼睛健康教育。

市场动态：揭示快速发展的人工泪液市场的关键市场洞察

供需的动态交互作用正在改变人工泪液市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球眼部疾病增加
    • 干眼症盛行率增加
    • 提高早期诊断、早期治疗的意识
  • 市场限制因素
    • 人工泪液的短期影响
  • 市场机会
    • 介绍具有更高稳定性的改良人工泪液
    • 大量投资开发创新人工泪液配方
  • 市场挑战
    • 使用受污染的人工泪液相关的风险

波特五力：开拓人工泪液市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解人工泪液市场的外部影响

外部宏观环境因素对人工泪液市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解人工泪液市场的竞争状况

对人工泪液市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵人工泪液市场供应商绩效评估

FPNV定位矩阵是评估人工泪液市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製人工泪液市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对人工泪液市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地眼科疾病的发生率正在上升
      • 干眼症盛行率增加
      • 提高对早期诊断和治疗的意识和趋势
    • 抑制因素
      • 人工泪液的短期影响
    • 机会
      • 介绍具有增强稳定性的改良人工泪液
      • 大力投资开发创新人工泪液配方
    • 任务
      • 使用受污染的人工泪液相关的风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人工泪液市场：依产品类型

  • 源自纤维素
  • 源自甘油
  • 油乳液
  • 聚乙二醇基
  • 丙二醇基
  • 透明质酸钠基质

第七章 人工泪液市场：依应用分类

  • 隐形眼镜里有水
  • 干眼症治疗

第八章 人工泪液市场（以交付方式）

  • 眼药水
  • 软膏

第九章美洲人工泪液市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太人工泪液市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲人工泪液市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Alcon Vision LLC
  • Bausch & Lomb Incorporated
  • Bayer AG
  • Horus Pharma
  • Johnson & Johnson Services, Inc.
  • Nicox SA
  • Novartis AG
  • Novax Pharma
  • Oasis Medical, Inc.
  • OCuSOFT Inc.
  • OmniVision GmbH
  • Otsuka Pharmaceutical Co., Ltd.
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Scope Ophthalmics Ltd.
  • Shire PLC by Takeda Pharmaceutical Company Limited
  • Similasan Corporation
  • Sun Pharmaceutical Industries, Inc.
  • Taiwan Biotech Co., Ltd.
  • Thea Pharmaceuticals Ltd.
  • URSAPHARM Arzneimittel GmbH
  • Visufarma
  • ZEISS Group
Product Code: MRR-69324464D1AA

The Artificial Tears Market was valued at USD 2.06 billion in 2023, expected to reach USD 2.23 billion in 2024, and is projected to grow at a CAGR of 8.27%, to USD 3.60 billion by 2030.

The artificial tears market focuses on products designed to lubricate and hydrate the eyes, primarily used to alleviate dryness and irritation. The necessity for artificial tears arises from various conditions such as dry eye syndrome, prolonged screen time, aging, and environmental factors. Applications of artificial tears are expanding beyond mere eye hydration to include post-surgery care and enhanced visual comfort for contact lens users. End users range from individual consumers to healthcare facilities, providing broad scope across retail and medical sectors. Key growth influencers include increasing digital device usage leading to eye strain, a growing aging population more susceptible to dry eye conditions, and innovations in product formulations, like preservative-free options and advanced delivery systems. Recent opportunities stem from the rise in awareness about eye health and increased demand for over-the-counter (OTC) products, emphasizing the need for brands to enhance presence in retail and e-commerce channels.

KEY MARKET STATISTICS
Base Year [2023] USD 2.06 billion
Estimated Year [2024] USD 2.23 billion
Forecast Year [2030] USD 3.60 billion
CAGR (%) 8.27%

However, market growth faces challenges such as product recall incidents affecting consumer trust and stringent regulatory hurdles governing medical products. Competition from established pharmaceutical companies and brand loyalty also pose significant barriers. Innovation opportunities are ripe in areas like developing multifunctional artificial tears, eco-friendly packaging, and personalized eye care solutions using AI. Thus, companies should invest in R&D for novel formulations and leverage digital marketing to captivate tech-savvy consumers. Additionally, partnerships with healthcare providers can enhance distribution networks. Understanding regional variances in regulatory landscapes and consumer behaviors is vital for optimizing market penetration strategies. While the market is currently consumer-driven with a growth focus in North America and Asia-Pacific regions, strategic geographic expansions, coupled with investments in technology, can amplify future growth prospects. Businesses must align with sustainability trends and prioritize consumer education about eye health to fully capitalize on market opportunities while addressing inherent challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Tears Market

The Artificial Tears Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of eye disorders worldwide
    • Increasing prevalence of dry eye syndrome
    • Growing awareness and inclination towards early diagnosis and treatment
  • Market Restraints
    • Short-term effects of artificial tears
  • Market Opportunities
    • Introduction of improved artificial tears with enhanced stability
    • Significant investments in developing innovative artificial tear formulations
  • Market Challenges
    • Risk pertaining to the use of contaminated artificial tears

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Tears Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Tears Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Tears Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Tears Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Tears Market

A detailed market share analysis in the Artificial Tears Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Tears Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Tears Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Tears Market

A strategic analysis of the Artificial Tears Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Tears Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Vision LLC, Bausch & Lomb Incorporated, Bayer AG, Horus Pharma, Johnson & Johnson Services, Inc., Nicox S.A., Novartis AG, Novax Pharma, Oasis Medical, Inc., OCuSOFT Inc., OmniVision GmbH, Otsuka Pharmaceutical Co., Ltd., Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co., Ltd., Scope Ophthalmics Ltd., Shire PLC by Takeda Pharmaceutical Company Limited, Similasan Corporation, Sun Pharmaceutical Industries, Inc., Taiwan Biotech Co., Ltd., Thea Pharmaceuticals Ltd., URSAPHARM Arzneimittel GmbH, Visufarma, and ZEISS Group.

Market Segmentation & Coverage

This research report categorizes the Artificial Tears Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cellulose-derived, Glycerin-derived, Oil-based Emulsion, Polyethylene Glycol-based, Propylene Glycol-based, and Sodium Hyaluronate-based.
  • Based on Application, market is studied across Contact Lens Moisture and Dry Eye Treatment.
  • Based on Delivery Mode, market is studied across Eye Drops and Ointments.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of eye disorders worldwide
      • 5.1.1.2. Increasing prevalence of dry eye syndrome
      • 5.1.1.3. Growing awareness and inclination towards early diagnosis and treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Short-term effects of artificial tears
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of improved artificial tears with enhanced stability
      • 5.1.3.2. Significant investments in developing innovative artificial tear formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Risk pertaining to the use of contaminated artificial tears
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Tears Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cellulose-derived
  • 6.3. Glycerin-derived
  • 6.4. Oil-based Emulsion
  • 6.5. Polyethylene Glycol-based
  • 6.6. Propylene Glycol-based
  • 6.7. Sodium Hyaluronate-based

7. Artificial Tears Market, by Application

  • 7.1. Introduction
  • 7.2. Contact Lens Moisture
  • 7.3. Dry Eye Treatment

8. Artificial Tears Market, by Delivery Mode

  • 8.1. Introduction
  • 8.2. Eye Drops
  • 8.3. Ointments

9. Americas Artificial Tears Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Tears Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Tears Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Alcon Vision LLC
  • 3. Bausch & Lomb Incorporated
  • 4. Bayer AG
  • 5. Horus Pharma
  • 6. Johnson & Johnson Services, Inc.
  • 7. Nicox S.A.
  • 8. Novartis AG
  • 9. Novax Pharma
  • 10. Oasis Medical, Inc.
  • 11. OCuSOFT Inc.
  • 12. OmniVision GmbH
  • 13. Otsuka Pharmaceutical Co., Ltd.
  • 14. Prestige Consumer Healthcare Inc.
  • 15. Santen Pharmaceutical Co., Ltd.
  • 16. Scope Ophthalmics Ltd.
  • 17. Shire PLC by Takeda Pharmaceutical Company Limited
  • 18. Similasan Corporation
  • 19. Sun Pharmaceutical Industries, Inc.
  • 20. Taiwan Biotech Co., Ltd.
  • 21. Thea Pharmaceuticals Ltd.
  • 22. URSAPHARM Arzneimittel GmbH
  • 23. Visufarma
  • 24. ZEISS Group

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL TEARS MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL TEARS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL TEARS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ARTIFICIAL TEARS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ARTIFICIAL TEARS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL TEARS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL TEARS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL TEARS MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CELLULOSE-DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GLYCERIN-DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OIL-BASED EMULSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POLYETHYLENE GLYCOL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PROPYLENE GLYCOL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SODIUM HYALURONATE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CONTACT LENS MOISTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 147. ARTIFICIAL TEARS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. ARTIFICIAL TEARS MARKET, FPNV POSITIONING MATRIX, 2023